Marketplaces Series C Investors & VC Firms
73 firms in this list, with a median first check of $1M. 35 of them lead rounds. Generated from verified public data and updated continuously.
LB Investment
SeoulSeries A–Late Stage
32 people
FELIX CAPITAL
LondonSeed–Growth$1M – $20M
47 people
Kaszek Ventures
MontevideoSeed–Late Stage
25 people
MONASHEES
São PauloPre-Seed–Growth$10M
31 people
Target Global
BerlinSeed–Late Stage
20 people
Globis Capital Partners
TokyoSeed–Growth$18M
17 people
Amadeus Capital Partners
LondonPre-Seed–Growth$50K – $12.7M
28 people
AppWorks Ventures
TaipeiPre-Seed–Series C$200K – $15M
26 people
BY Venture Partners
St HelierPre-Seed–Series C$100K – $1M
15 people
OMERS Ventures
TorontoPre-Seed–Series C$5M – $25M
15 people
Burda Principal Investments
MunichSeries A–Late Stage
29 people
Autotech Ventures
Menlo ParkPre-Seed–Series C$1M – $8M
24 people
IDC Ventures
MiamiPre-Seed–Growth
42 people
Rakuten Capital
TokyoSeed–Late Stage
21 people
Aglae Ventures
ParisSeed–Late Stage$108K – $5.4M
9 people
Hedosophia
LondonSeries A–Series C
31 people
Fundamentum
GurugramSeries B–Series C$10M – $25M
16 people
Softbank Latin America Fund
MiamiSeed–Growth
11 people
Prime Ventures
AmsterdamSeed–Series C$5.4M – $16.2M
8 people
Zigg Capital
New YorkSeed–Series C$4M
9 people
Rethink Impact
WashingtonSeed–Series C$2M – $10M
8 people
Asia Partners
SingaporeSeries C–Growth$20M – $100M
24 people
Sapien Ventures / Sapien Group
ChatswoodSeed–Growth
24 people
Invus
New YorkSeed–Late Stage
8 people
Related lists
Series C Investors & VC Firms (1709)Series C Investors & VC Firms in North America (942)Series C Investors & VC Firms in United States (826)Series C Investors & VC Firms in Global (662)Series C Investors & VC Firms in Europe (661)Healthtech Series C Investors & VC Firms (564)SaaS Series C Investors & VC Firms (557)Fintech Series C Investors & VC Firms (535)Series C Investors & VC Firms in Asia-Pacific (533)Enterprise Software Series C Investors & VC Firms (526)
Data sourced from public filings and firms' own websites — see our methodology.








































































































